May 20, 2022
1 min read
Save
EDIT-CMD
Issue: May 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Diltiazem vs. placebo for coronary vasomotor dysfunction in patients with angina and nonobstructive CAD.